title: Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement.
authors: K
authors: K
authors: Ishibashi
authors: S M
authors: SM
authors: Berman
authors: G
authors: G
authors: Paz-Filho
authors: B
authors: B
authors: Lee
authors: C
authors: C
authors: Robertson
authors: M A
authors: MA
authors: Mandelkern
authors: M L
authors: ML
authors: Wong
authors: J
authors: J
authors: Licinio
authors: E D
authors: ED
authors: London
mesh_terms: D000328:Adult; D001549:Benzamides; D016022:Case-Control Studies; D003342:Corpus Striatum / Q000378:metabolism; D005260:Female; D005462:Fluorine Radioisotopes; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D020738:Leptin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000172:deficiency* / Q000235:genetics / Q000627:therapeutic use; D008297:Male; D020125:Mutation, Missense; D011869:Radioligand Assay / Q000379:methods; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D050637:Receptors, Dopamine D3 / Q000378:metabolism*
chemical_list: D001549:Benzamides; D005462:Fluorine Radioisotopes; D020738:Leptin; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; C122136:recombinant methionyl human leptin; C574003:fallypride